APO Research
Talk to an analyst

APO RESEARCH · REPORT

Acetaminophen Injection

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Acetaminophen Injection Market Outlook and Growth Opportunities 2026

29 December 2025199 pages

Choose your research edition.

Industry ResearchAcetaminophen Injection Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Acetaminophen Injection Industry Growth and Trends Forecast to 203289 pages · $3,450 USDMarket StructureGlobal Acetaminophen Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Acetaminophen Injection Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Acetaminophen Injection Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Acetaminophen Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Acetaminophen Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Acetaminophen Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Acetaminophen Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Acetaminophen Injection market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Acetaminophen Injection market include Accord Healthcare, Eugia, Fresenius Kabi, Hikma, Mallinckrodt, Terumo, B. Braun Medical, Pfizer and Sandoz, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Acetaminophen Injection market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Acetaminophen Injection and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Acetaminophen Injection revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Acetaminophen Injection market.

Acetaminophen Injection Segment by Company

Accord Healthcare

Eugia

Fresenius Kabi

Hikma

Mallinckrodt

Terumo

B. Braun Medical

Pfizer

Sandoz

Acetaminophen Injection Segment by Type

150mg/mL

10mg/mL

100mg/mL

Acetaminophen Injection Segment by Application

Hospital

Clinic

Acetaminophen Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Acetaminophen Injection status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Acetaminophen Injection key companies, revenue, market share, and recent developments.

3. To split the Acetaminophen Injection breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Acetaminophen Injection market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Acetaminophen Injection significant trends, drivers, influence factors in global and regions.

6. To analyze Acetaminophen Injection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Acetaminophen Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Acetaminophen Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Acetaminophen Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Acetaminophen Injection industry.

Chapter 3: Detailed analysis of Acetaminophen Injection company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Acetaminophen Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Acetaminophen Injection in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Acetaminophen Injection Industry Trends Table 2. Acetaminophen Injection Industry Drivers Table 3. Acetaminophen Injection Industry Opportunities and Challenges Table 4. Acetaminophen Injection Industry Restraints Table 5. Global Acetaminophen Injection Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Acetaminophen Injection Revenue Share by Company (2021-2026) Table 7. Global Acetaminophen Injection Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Acetaminophen Injection Key Company Manufacturing Base & Headquarters Table 9. Global Acetaminophen Injection Company, Product Type & Application Table 10. Global Acetaminophen Injection Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Acetaminophen Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of 150mg/mL Table 15. Significant Companies of 10mg/mL Table 16. Significant Companies of 100mg/mL Table 17. Global Acetaminophen Injection Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Acetaminophen Injection Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Acetaminophen Injection Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Acetaminophen Injection Sales Value Share by Type (2021-2026) Table 21. Global Acetaminophen Injection Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Hospital Table 23. Significant Companies of Clinic Table 24. Global Acetaminophen Injection Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Acetaminophen Injection Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Acetaminophen Injection Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Acetaminophen Injection Sales Value Share by Application (2021-2026) Table 28. Global Acetaminophen Injection Sales Value Share by Application (2027-2032) Table 29. Global Acetaminophen Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Acetaminophen Injection Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Acetaminophen Injection Sales Value Share by Region (2021-2026) Table 32. Global Acetaminophen Injection Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Acetaminophen Injection Sales Value Share by Region (2027-2032) Table 34. Global Acetaminophen Injection Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Acetaminophen Injection Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Acetaminophen Injection Sales Value Market Share by Country (2021-2026) Table 37. Global Acetaminophen Injection Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Acetaminophen Injection Sales Value Market Share by Country (2027-2032) Table 39. Accord Healthcare Company Information Table 40. Accord Healthcare Business Overview Table 41. Accord Healthcare Acetaminophen Injection Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Accord Healthcare Acetaminophen Injection Product Portfolio Table 43. Accord Healthcare Recent Development Table 44. Eugia Company Information Table 45. Eugia Business Overview Table 46. Eugia Acetaminophen Injection Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Eugia Acetaminophen Injection Product Portfolio Table 48. Eugia Recent Development Table 49. Fresenius Kabi Company Information Table 50. Fresenius Kabi Business Overview Table 51. Fresenius Kabi Acetaminophen Injection Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Fresenius Kabi Acetaminophen Injection Product Portfolio Table 53. Fresenius Kabi Recent Development Table 54. Hikma Company Information Table 55. Hikma Business Overview Table 56. Hikma Acetaminophen Injection Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Hikma Acetaminophen Injection Product Portfolio Table 58. Hikma Recent Development Table 59. Mallinckrodt Company Information Table 60. Mallinckrodt Business Overview Table 61. Mallinckrodt Acetaminophen Injection Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Mallinckrodt Acetaminophen Injection Product Portfolio Table 63. Mallinckrodt Recent Development Table 64. Terumo Company Information Table 65. Terumo Business Overview Table 66. Terumo Acetaminophen Injection Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Terumo Acetaminophen Injection Product Portfolio Table 68. Terumo Recent Development Table 69. B. Braun Medical Company Information Table 70. B. Braun Medical Business Overview Table 71. B. Braun Medical Acetaminophen Injection Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. B. Braun Medical Acetaminophen Injection Product Portfolio Table 73. B. Braun Medical Recent Development Table 74. Pfizer Company Information Table 75. Pfizer Business Overview Table 76. Pfizer Acetaminophen Injection Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Pfizer Acetaminophen Injection Product Portfolio Table 78. Pfizer Recent Development Table 79. Sandoz Company Information Table 80. Sandoz Business Overview Table 81. Sandoz Acetaminophen Injection Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Sandoz Acetaminophen Injection Product Portfolio Table 83. Sandoz Recent Development Table 84. Research Programs/Design for This Report Table 85. Authors List of This Report Table 86. Secondary Sources Table 87. Primary Sources List of Figures Figure 1. Acetaminophen Injection Product Image Figure 2. Global Acetaminophen Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Acetaminophen Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Acetaminophen Injection Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. 150mg/mL Image Figure 8. 10mg/mL Image Figure 9. 100mg/mL Image Figure 10. Global Acetaminophen Injection Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Acetaminophen Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Acetaminophen Injection Sales Value Share by Type (2021-2032) Figure 13. Hospital Image Figure 14. Clinic Image Figure 15. Global Acetaminophen Injection Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Acetaminophen Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Acetaminophen Injection Sales Value Share by Application (2021-2032) Figure 18. Global Acetaminophen Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Acetaminophen Injection Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Acetaminophen Injection Sales Value (2021-2032) & (US$ Million) Figure 21. North America Acetaminophen Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Acetaminophen Injection Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Acetaminophen Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Acetaminophen Injection Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Acetaminophen Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Acetaminophen Injection Sales Value (2021-2032) & (US$ Million) Figure 27. South America Acetaminophen Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Acetaminophen Injection Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Acetaminophen Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Acetaminophen Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Acetaminophen Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Acetaminophen Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Acetaminophen Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Acetaminophen Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Acetaminophen Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Acetaminophen Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Acetaminophen Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Acetaminophen Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Acetaminophen Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Acetaminophen Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Acetaminophen Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Acetaminophen Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Acetaminophen Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Acetaminophen Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Acetaminophen Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Acetaminophen Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Acetaminophen Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Acetaminophen Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Acetaminophen Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Acetaminophen Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Acetaminophen Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Acetaminophen Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Acetaminophen Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Acetaminophen Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Acetaminophen Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Acetaminophen Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Acetaminophen Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Acetaminophen Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Acetaminophen Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Acetaminophen Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Acetaminophen Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Acetaminophen Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Acetaminophen Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Acetaminophen Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Acetaminophen Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Acetaminophen Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Acetaminophen Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Acetaminophen Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Acetaminophen Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Acetaminophen Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Acetaminophen Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Acetaminophen Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Acetaminophen Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Acetaminophen Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Acetaminophen Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Acetaminophen Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Acetaminophen Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Acetaminophen Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Acetaminophen Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Acetaminophen Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Acetaminophen Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Acetaminophen Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Acetaminophen Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Acetaminophen Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Acetaminophen Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Acetaminophen Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Acetaminophen Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Acetaminophen Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Acetaminophen Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Acetaminophen Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Acetaminophen Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Acetaminophen Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Acetaminophen Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Acetaminophen Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Acetaminophen Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Acetaminophen Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Acetaminophen Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Acetaminophen Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Acetaminophen Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Acetaminophen Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Acetaminophen Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Acetaminophen Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Acetaminophen Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Acetaminophen Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Acetaminophen Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Acetaminophen Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Acetaminophen Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Acetaminophen Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Acetaminophen Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Acetaminophen Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Acetaminophen Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Acetaminophen Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Acetaminophen Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • 150mg/mL
  • 10mg/mL
  • 100mg/mL
Applications
  • Hospital
  • Clinic
Companies covered
  • Accord Healthcare
  • Eugia
  • Fresenius Kabi
  • Hikma
  • Mallinckrodt
  • Terumo
  • B. Braun Medical
  • Pfizer
  • Sandoz

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Acetaminophen Injection Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Acetaminophen Injection Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Acetaminophen Injection Market Dynamics
  1. 2.1 Acetaminophen Injection Industry Trends
  2. 2.2 Acetaminophen Injection Industry Drivers
  3. 2.3 Acetaminophen Injection Industry Opportunities and Challenges
  4. 2.4 Acetaminophen Injection Industry Restraints
3 Acetaminophen Injection Market by Company
  1. 3.1 Global Acetaminophen Injection Company Revenue Ranking in 2025
  2. 3.2 Global Acetaminophen Injection Revenue by Company (2021-2026)
  3. 3.3 Global Acetaminophen Injection Company Ranking (2024-2026)
  4. 3.4 Global Acetaminophen Injection Company Manufacturing Base and Headquarters
  5. 3.5 Global Acetaminophen Injection Company Product Type and Application
  6. 3.6 Global Acetaminophen Injection Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Acetaminophen Injection Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Acetaminophen Injection Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Acetaminophen Injection Market by Type
  1. 4.1 Acetaminophen Injection Type Introduction
  2. 4.1.1 150mg/mL
  3. 4.1.2 10mg/mL
  4. 4.1.3 100mg/mL
  5. 4.2 Global Acetaminophen Injection Sales Value by Type
  6. 4.2.1 Global Acetaminophen Injection Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Acetaminophen Injection Sales Value by Type (2021-2032)
  8. 4.2.3 Global Acetaminophen Injection Sales Value Share by Type (2021-2032)
5 Acetaminophen Injection Market by Application
  1. 5.1 Acetaminophen Injection Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Acetaminophen Injection Sales Value by Application
  5. 5.2.1 Global Acetaminophen Injection Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Acetaminophen Injection Sales Value by Application (2021-2032)
  7. 5.2.3 Global Acetaminophen Injection Sales Value Share by Application (2021-2032)
6 Acetaminophen Injection Regional Value Analysis
  1. 6.1 Global Acetaminophen Injection Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Acetaminophen Injection Sales Value by Region (2021-2032)
  3. 6.2.1 Global Acetaminophen Injection Sales Value by Region: 2021-2026
  4. 6.2.2 Global Acetaminophen Injection Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Acetaminophen Injection Sales Value (2021-2032)
  7. 6.3.2 North America Acetaminophen Injection Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Acetaminophen Injection Sales Value (2021-2032)
  10. 6.4.2 Europe Acetaminophen Injection Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Acetaminophen Injection Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Acetaminophen Injection Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Acetaminophen Injection Sales Value (2021-2032)
  16. 6.6.2 South America Acetaminophen Injection Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Acetaminophen Injection Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Acetaminophen Injection Sales Value Share by Country, 2025 VS 2032
7 Acetaminophen Injection Country-level Value Analysis
  1. 7.1 Global Acetaminophen Injection Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Acetaminophen Injection Sales Value by Country (2021-2032)
  3. 7.2.1 Global Acetaminophen Injection Sales Value by Country (2021-2026)
  4. 7.2.2 Global Acetaminophen Injection Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Acetaminophen Injection Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Acetaminophen Injection Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Acetaminophen Injection Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Acetaminophen Injection Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Acetaminophen Injection Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Acetaminophen Injection Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Acetaminophen Injection Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Acetaminophen Injection Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Acetaminophen Injection Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Acetaminophen Injection Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Acetaminophen Injection Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Acetaminophen Injection Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Acetaminophen Injection Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Acetaminophen Injection Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Acetaminophen Injection Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Acetaminophen Injection Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Acetaminophen Injection Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Acetaminophen Injection Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Acetaminophen Injection Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Acetaminophen Injection Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Acetaminophen Injection Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Acetaminophen Injection Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Acetaminophen Injection Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Acetaminophen Injection Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Acetaminophen Injection Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Acetaminophen Injection Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Acetaminophen Injection Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Acetaminophen Injection Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Acetaminophen Injection Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Acetaminophen Injection Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Acetaminophen Injection Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Acetaminophen Injection Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Acetaminophen Injection Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Acetaminophen Injection Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Acetaminophen Injection Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Acetaminophen Injection Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Acetaminophen Injection Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Acetaminophen Injection Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Acetaminophen Injection Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Acetaminophen Injection Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Acetaminophen Injection Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Acetaminophen Injection Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Acetaminophen Injection Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Acetaminophen Injection Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Acetaminophen Injection Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Acetaminophen Injection Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Acetaminophen Injection Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Acetaminophen Injection Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Acetaminophen Injection Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Acetaminophen Injection Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Acetaminophen Injection Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Acetaminophen Injection Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Acetaminophen Injection Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Acetaminophen Injection Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Acetaminophen Injection Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Acetaminophen Injection Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Acetaminophen Injection Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Acetaminophen Injection Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Acetaminophen Injection Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Acetaminophen Injection Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Acetaminophen Injection Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Acetaminophen Injection Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Acetaminophen Injection Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Acetaminophen Injection Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Acetaminophen Injection Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Acetaminophen Injection Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Acetaminophen Injection Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Acetaminophen Injection Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Acetaminophen Injection Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Acetaminophen Injection Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Acetaminophen Injection Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Acetaminophen Injection Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Acetaminophen Injection Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Acetaminophen Injection Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Acetaminophen Injection Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Acetaminophen Injection Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Acetaminophen Injection Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Acetaminophen Injection Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Acetaminophen Injection Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Acetaminophen Injection Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Acetaminophen Injection Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Acetaminophen Injection Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Acetaminophen Injection Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Acetaminophen Injection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Accord Healthcare
  2. 8.1.1 Accord Healthcare Company Information
  3. 8.1.2 Accord Healthcare Business Overview
  4. 8.1.3 Accord Healthcare Acetaminophen Injection Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Accord Healthcare Acetaminophen Injection Product Portfolio
  6. 8.1.5 Accord Healthcare Recent Developments
  7. 8.2 Eugia
  8. 8.2.1 Eugia Company Information
  9. 8.2.2 Eugia Business Overview
  10. 8.2.3 Eugia Acetaminophen Injection Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Eugia Acetaminophen Injection Product Portfolio
  12. 8.2.5 Eugia Recent Developments
  13. 8.3 Fresenius Kabi
  14. 8.3.1 Fresenius Kabi Company Information
  15. 8.3.2 Fresenius Kabi Business Overview
  16. 8.3.3 Fresenius Kabi Acetaminophen Injection Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Fresenius Kabi Acetaminophen Injection Product Portfolio
  18. 8.3.5 Fresenius Kabi Recent Developments
  19. 8.4 Hikma
  20. 8.4.1 Hikma Company Information
  21. 8.4.2 Hikma Business Overview
  22. 8.4.3 Hikma Acetaminophen Injection Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Hikma Acetaminophen Injection Product Portfolio
  24. 8.4.5 Hikma Recent Developments
  25. 8.5 Mallinckrodt
  26. 8.5.1 Mallinckrodt Company Information
  27. 8.5.2 Mallinckrodt Business Overview
  28. 8.5.3 Mallinckrodt Acetaminophen Injection Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Mallinckrodt Acetaminophen Injection Product Portfolio
  30. 8.5.5 Mallinckrodt Recent Developments
  31. 8.6 Terumo
  32. 8.6.1 Terumo Company Information
  33. 8.6.2 Terumo Business Overview
  34. 8.6.3 Terumo Acetaminophen Injection Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Terumo Acetaminophen Injection Product Portfolio
  36. 8.6.5 Terumo Recent Developments
  37. 8.7 B. Braun Medical
  38. 8.7.1 B. Braun Medical Company Information
  39. 8.7.2 B. Braun Medical Business Overview
  40. 8.7.3 B. Braun Medical Acetaminophen Injection Revenue and Gross Margin (2021-2026)
  41. 8.7.4 B. Braun Medical Acetaminophen Injection Product Portfolio
  42. 8.7.5 B. Braun Medical Recent Developments
  43. 8.8 Pfizer
  44. 8.8.1 Pfizer Company Information
  45. 8.8.2 Pfizer Business Overview
  46. 8.8.3 Pfizer Acetaminophen Injection Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Pfizer Acetaminophen Injection Product Portfolio
  48. 8.8.5 Pfizer Recent Developments
  49. 8.9 Sandoz
  50. 8.9.1 Sandoz Company Information
  51. 8.9.2 Sandoz Business Overview
  52. 8.9.3 Sandoz Acetaminophen Injection Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Sandoz Acetaminophen Injection Product Portfolio
  54. 8.9.5 Sandoz Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst